A TQTc Study for Omaveloxolone

NCT05927649 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Health Adult Subjects

Interventions

DRUG: Omaveloxolone
DRUG: Moxifloxacin

Sponsor

Biogen

Collaborators

[object Object]
[object Object]